Treatment with nanosomal paclitaxel lipid suspension versus conventional paclitaxel in metastatic breast cancer patients - a multicenter, randomized, comparative, phase II/III clinical study.

Chiradoni Thungappa SatheeshRakesh TaranJitendra Kumar SinghShanti Prakash ShrivastavNikunj K VithalaniKalyan Kusum MukherjeeRajnish Vasant NagarkarTanveer MaksudAjay Omprakash MehtaKrishnan SrinivasanMummaneni VikranthSatish Ramkrishna SonawaneAteeq AhmadSaifuddin SheikhShoukath M AliRonak PatelMahesh PaithankarLav PatelAnil RajaniDeepak BungerAlok ChaturvediImran Ahmad

Published in: Therapeutic advances in medical oncology (2024)

Clinical Trial Registry-India (CTRI), CTRI/2010/091/001344 Registered on: 18 October 2010 (https://ctri.nic.in/Clinicaltrials/pmaindet2.php?EncHid=MjEzNQ==&Enc=&userName=CTRI/2010/091/001344), CTRI/2015/07/006062 Registered on: 31 July 2015 (https://ctri.nic.in/Clinicaltrials/pmaindet2.php?EncHid=MTE2Mjc=&Enc=&userName=CTRI/2015/07/006062).

Keyphrases

phase ii
double blind
clinical trial
placebo controlled
open label
phase iii
small cell lung cancer
study protocol
squamous cell carcinoma
randomized controlled trial
fatty acid
cross sectional
chemotherapy induced